Ligand Acquires Assets Of Novan, Inc. For $12.2M; Remaining Commercial Assets Of EPI Health To Be Sold To Other Parties
Portfolio Pulse from Benzinga Newsdesk
Ligand Pharmaceuticals has acquired the assets of Novan, Inc. for $12.2 million. The remaining commercial assets of EPI Health are to be sold to other parties.
September 27, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ligand Pharmaceuticals has expanded its portfolio by acquiring the assets of Novan, Inc. This could potentially increase the company's revenue streams.
Acquisitions often lead to an increase in a company's assets and potential revenue streams. This acquisition could therefore have a positive impact on Ligand's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100